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Abstract
Context: Being born very preterm is associated with elevated risk for neonatal mortality. The aim of this review is to give an
overview of prediction models for mortality in very premature infants, assess their quality, identify important predictor
variables, and provide recommendations for development of future models.
Methods: Studies were included which reported the predictive performance of a model for mortality in a very preterm or
very low birth weight population, and classified as development, validation, or impact studies. For each development study,
we recorded the population, variables, aim, predictive performance of the model, and the number of times each model had
been validated. Reporting quality criteria and minimum methodological criteria were established and assessed for
development studies.
Results: We identified 41 development studies and 18 validation studies. In addition to gestational age and birth weight, eight
variables frequently predicted survival: being of average size for gestational age, female gender, non-white ethnicity, absence of
serious congenital malformations, use of antenatal steroids, higher 5-minute Apgar score, normaltemperature on admission, and
better respiratory status. Twelve studies met our methodological criteria, three of which have been externally validated. Low
reporting scores were seen in reporting of performance measures, internal and external validation, and handling of missing data.
Conclusions: Multivariate models can predict mortality better than birth weight or gestational age alone in very preterm
infants. There are validated prediction models for classification and case-mix adjustment. Additional research is needed in
validation and impact studies of existing models, and in prediction of mortality in the clinically important subgroup of
infants where age and weight alone give only an equivocal prognosis.
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Introduction
Preterm birth is the single largest contributer to neonatal
mortality in developed countries [1]. Mortality risks are especially
high in the very low gestational age (VLGA, less than 32 weeks)
and very low birth weight (VLBW, less than 1500 g) populations,
and survival is even less certain in the ELGA/BW infants
(extremely low gestational age/birth weight, less than 28 weeks
and less than 1000 g). Physicians and parents are faced with
difficult decisions at every stage of care: deciding if and when to
intervene with Cesarean section, whether resuscitation should be
attempted and mechanical ventilation or other treatments should
be initiated, and whether and when treatment should be
withdrawn. An accurate prognosis could help ease these difficult
decisions. Consequently, prediction of mortality in very preterm
infants is of the utmost importance.
Multivariate prediction models combine individual patient
characteristics to predict a diagnostic or prognostic outcome [2].
Prediction models can be used to make a prognosis for an
individual patient, or to stratify patients in the arms of a clinical
trial, or for case-mix adjustment when comparing two populations
in quality improvement efforts [3].
A clinician or researcher who wishes to use a prediction model
in their country or setting can choose between using an existing
model, recalibrating and validating an existing model (determining
if it performs well in the local population), or creating a new model
(if datasets are available). While there are many existing models for
predicting mortality in very preterm infants, there is no overview
of these models and their quality.
The objective of this review is to systematically review models
for the prediction of mortality in very premature infants, identify
promising variables which are frequently significant in multivariate
models, and assess the quality of these models in order to provide
recommendations for future research.
Methods
Study selection
The Cochrane library of systematic reviews was searched and
no reviews on this subject were found. The MedLine database was
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followed the general form: prediction model AND preterm AND
infant AND mortality. A complete list of search terms is given in
Table S1.
The articles were divided among three reviewers (SM, AR, and
AAH) such that two independently inspected each title and
abstract, and marked those relevant for inclusion. Disagreement
was resolved by discussion with all three reviewers. The full texts of
the selected articles were then reviewed for final inclusion and
divided into studies describing development of new models, studies
which validated an existing model, and studies of the model’s
impact on clinical decision making. The references of included
studies were searched manually to identify additional articles, and
articles citing the included papers were identified and checked.
The search was limited to articles available in English, excluding
letters and comments.
Inclusion criteria
The inclusion criteria were:
N The study should report on a population of live-born infants
born at less than 32 weeks gestational age and/or less than
1500 g birth weight. Prediction models for a gestational age-
or birth weight-specific subpopulation were included. Studies
which used a slightly broader definition of VLGA/BW or
ELGA/BW were included. Prediction models for a subpop-
ulation with a specific disease or condition (for example,
VLBW infants with necrotizing enterocolitis) were excluded.
Prediction models for a general neonatal intensive care unit
(NICU) population were excluded unless they reported
performance separately for VLGA/BW infants.
N The outcome which the prediction model predicts is neonatal
mortality or survival, or a combined outcome which includes
mortality or survival. Studies which report on both stillbirth
and neonatal mortality are included.
N The purpose of the model is to predict the probability of
survival, rather than to investigate a single specific risk factor.
N The study must report at least one measure of the predictive
performance of a multivariate model (discrimination, calibra-
tion, or accuracy).
Data collection and analysis
Included studies were classified as development, validation, or
impact studies. Development studies describe and assess the
performance of a prediction model which was not previously
published, or modified a previous model by adding or removing
variables. Validation studies assess the performance of a previously
published prediction model in a new population, or recalibrate a
previous model by mathematically adjusting the model without
changing the variables used. Impact studies assess the effect a
prediction model has on clinical decisions. Validation studies were
used only to count the number of times a model described in a
development study had been validated. From each development
study, data were collected on the study population, the prediction
model or models developed, the performance and validation of the
prediction model, and the quality of the study, using a structured
data collection form.
Population. The population is defined by the range of
gestational ages or birth weights, the setting, study year, and
(postpartum) age of the infants at inclusion in the study. Maturity
(gestational age and/or birth weight) is a strong predictor for
mortality, and thus models with a wide range of gestational ages
and birth weights are expected to have better performance
measures. The study year and setting indicate whether treatments
such as surfactant and antenatal steroids were available. The age
of the infant at inclusion (for example at the onset of labor, at live
birth, or at 24 hours postpartum) determines how long the infant
needed to survive before being included in the study population,
and thus strongly influences the composition of the study
population. This is due to the substantial mortality in each of
the early stages of life: intrapartum, in the delivery room, and in
the first hours of NICU care.
Since the performance of prediction models can only be
compared between similar populations, populations were classified
as VLGA/BW or ELGA/BW, developed or developing county,
pre- or post- surfactant era, and by mortality rate for the purpose
of comparing model performance. Mortality rates were considered
comparable if the absolute difference was #10%. Studies were
classified as pre- or post- surfactant based on the authors’ report of
surfactant use. In studies where surfactant use was not reported,
surfactant was assumed to be in routine use after 1995 in
developed countries.
Prediction models. The time of prediction and type of
prediction model were recorded. The time of prediction is the time
at which the prediction model can be used, e.g. models for
antenatal prediction versus prediction after NICU data is
available. The prediction model type was categorized as logistic
regression, neural network, classification tree, or other [2]. If
reported, the model (equation or score) was recorded.
Variables. The outcome variable and input variables were
collected for each prediction model. The input variables are the
potential predictors which were tested, both during model
development and in the final model. Interaction terms and
mathematical transformations were not considered new variables
(e.g. age and age
2 refer to the same input variable).
Performance measures. Performance measures (discrimi-
nation, calibration, and accuracy) and the range of probabilities
given by the prediction model were recorded. Discrimination measures
whether the prediction model gives higher probabilities to patients with
the event (e.g. patients who die) as opposed to patients without the
event, commonly measured by the AUC (Area Under the receiver
operating characteristic Curve). Calibration measures whether the
predicted probability is approximately correct (e.g. when the model
predicts a 30% chance of survival, then about 30% of patients are
expected to survive). Accuracy is a measure of how close, on average, a
prediction for a patient is to his or her actual outcome. The prediction
is usually a percent probability, but it can be categorized into 0 or 1
(survival or non-survival) based on a cutoff point. Measures of accuracy
may combine aspects of discrimination and calibration.
Different measures are important for different uses of prediction
models. The intended use of the prediction model was derived
from the aim or conclusions of the study and classified as
classification (e.g. classification into high and low risk), case-mix
adjustment (e.g. for quality control or benchmarking), clinical
decision-making, or other. The performance measures were
considered appropriate for the intended purpose if they included:
for classification, a measure of discrimination or accuracy; for
case-mix adjustment, a measure of discrimination and a measure
of calibration or accuracy; and for clinical decision-making, a
measure of discrimination, calibration, and the distribution or
range of probabilities given by the model [2]. The distribution or
range is particularly relevant for clinical usefulness, for example a
model which predicts a 10% probability of survival for some
infants and 90% for others is likely to be more useful than a model
which only gives predictions of 49% and 51%.
Validation. Validation assesses model performance. A
performance measure can be calculated from the same population
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tends to inflate performance due to leveraging on coincidental
correlations in the development population. A separate population
can be created statistically by sampling subpopulations (e.g.
bootstrapping), or by reserving a separate sample of patients for
validation. Internal validation tests performance in the same setting
where the model is developed, and external validation tests in a
different setting [4].
Quality assessment. A framework was developed for the
purpose of assessing the quality of the prediction models and
articles. The framework was synthesized from quality assessment
frameworks for prediction models of pregnancy in subfertile
couples [4] and for illness severity in adult ICU patients [5], and
recommendations for developing good prediction models [2,6].
The framework was divided into two sections: a reporting score
which assessed the quality of the article and a methodological
score which consists of a set of minimum criteria for developing a
valid prediction model. Each item in the scores was rated as no (0
points), partly (1 point), or yes (2 points). There were 19 items in
the reporting score for a total of 38 possible points, and 6 items in
the methodological score for a total of 12 possible points.
Results
Search results
The results of the search are summarized in Figure 1. The
search resulted in 1668 articles, of which 102 were provisionally
included on the basis of title and abstract. Review of the full text
retained 54 articles for inclusion. Review of the references and
cross-referencing of the included studies yielded a further 5
papers for inclusion, for a total of 59 studies. Of these, 41
described development of a previously unpublished model and 18
reported on validation of one or more previously published
models. No impact studies were found. Of the 41 studies
reporting on model development, 23 reported more than one
model (range =1–10, median =2), resulting in 103 unique
prediction models.
Study data and analysis
Table S2 summarizes the population, aim, performance
measures, validation, and quality of the 41 development studies.
Further details of these 41 studies can be found in Table S3.
Populations. The populations of the included studies were
heterogeneous. The studies included 28 which predicted outcome
for a general VLGA/BW population [7–34] and 13 studies
specific to ELGA/BW infants [35–47]. Of these 13 studies, 7
focused on the youngest and smallest of the ELGA/BW infants
[36,38,39,41,44–46].
Studies dated from 1982–2010. The included studies represent
populations from 21 countries, and seven of the included
prediction models are specifically for use in low-resource or
mixed-resource settings [16,25,27,30–32,34]. The number of
VLGA/BW infants included in each of the studies ranged from
59 [41] to 12960 [15], and the mortality rate among these infants
ranged from 6.8% [28] to 59.6% [37]. Infants were included in the
study population at the onset of labor/decision to deliver in 3
studies, at live birth in 12 studies, on NICU admission or the start
of mechanical ventilation in 13 studies, after survival of 1–
24 hours in 5 studies, or survival for .1 day in 4 studies. The
(postpartum) age of the infant at inclusion in the study was not
reported in 6 studies.
Prediction models. The times of prediction are summarized
in Figure 2. Five studies include a prediction model which is
intended to make an antenatal prediction, two of these for ELGA/
BW infants. Seventeen studies developed a prediction model for
making predictions using data available at birth, while a further
eight use NICU admission data or data available at the start of
mechanical ventilation. Twelve studies, including the Clinical Risk
Index for Babies (CRIB [13]) and Score for Neonatal Acute
Physiology-II (SNAP-II [23]), use data from the first few hours of
life. Six studies include a prediction model which uses data
available after the first day, and two studies do not specify when
the data used to develop the prediction model were collected. Nine
studies include multiple prediction models with different times of
prediction [19,22,24,33,36,42–44,47]. Six of these compare
Figure 1. Results of search. This review focuses on the 41 development studies, which describe previously unpublished models predicting
mortality.
doi:10.1371/journal.pone.0023441.g001
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that the addition of later data made little difference in the
predictive performance of the models.
The majority of the included studies used a logistic regression
model (35/41), with the others reporting on a classification tree
[43], a log linear regression model [15], discriminant analysis
[8,35,37], and a score based on expert opinion [24]. Four studies
compared the performance of two different types of prediction
models, three of which compared logistic regression to a neural
network model. In one the neural network performed better
(AUC =0.954 vs. 0.917, p=0.002 by the univariate Z-score test
of the difference in AUCs [21]), in the others the performance was
approximately equal (AUC =0.87 in both models [40], and
slightly better performance from the regression model in 3/5
scenarios [42]). The fourth study used both a CART (Classifica-
tion And Regression Tree) model and logistic regression, but did
not report the same outcome measures for the two models [29].
Dependent variable (outcome). Most prediction models in
this review (33) predict mortality, the remainder (8) predict
survival. The observation period is 28 days (neonatal mortality) or
the duration of hospital stay in 30/41 studies. Since late deaths are
a very small fraction of the mortality in this population, it is
expected that longer observation will not affect the choice of
variables, their weight or significance in the final model, or the
performance of the model.
Three studies indicated that infants who survived ‘‘against the
odds’’ had a poor neurologic outcome [15,36,42]. However,
models with a combined outcome of mortality and morbidity did
not show better performance than models predicting mortality
alone in studies which compared the two [16,29,39,45–47].
Independent variables (predictors). The 41 included
studies investigated a total of 254 different input variables. A
table showing categories of variables included in each study is
given in Table S4. A complete list of the exact variables tested and
their univariate and multivariate significance is available from the
authors upon request.
In addition to higher gestational age and birth weight, 7 input
variables were tested in 10 or more studies and were frequently
found to predict improved survival in multivariate models: being
of average size for gestational age (10/22 studies); female gender
(18/30 studies); non-white ethnicity (9/20 studies); use of antenatal
steroids (11/20 studies); higher Apgar score (18/26 studies);
normal temperature on admission (5/12 studies); and a measure of
respiratory status such as blood gas (11/16 studies), FiO2 (6/7
studies), or clinical respiratory function (9/19 studies).
Congenital malformation is often an exclusion criterion rather
than an input variable and therefore was not an input variable
in many studies, but was often significant when tested (4/8
studies). Multiple gestation showed an inconsistent effect. It was
included in the final model in 8/20 studies, but showed a
protective effect for singleton infants in 6 studies and multiple
infants in 2 studies. Hospital care factors were variably
significant, such as inborn/outborn status (3/10 studies) and
hospital of birth (4/8 studies).
A number of input variables were frequently tested, but usually
did not remain significant in the final models. Such variables
include: maternal health risks (0/10 studies, except hypertension/
preeclampsia which had a protective effect in 4/11 studies),
maternal age (2/12 studies), premature rupture of membranes (1/
10 studies), presentation (0/10), mode of delivery (2/25 studies),
and infant morbidities (4/17 studies, with the exception of seizures
(3/6 studies) and shock (2/2 studies)).
Performance measures. A summary of the reported
performance measures is given in Table 1. The most common
measure reported was the p-value of the Hosmer-Lemeshow
statistics (19/41 studies), followed by the AUC (18/41 studies).
Performance measures for the 103 models and the equations or
scores used to make a prediction are provided in Table S3.
Performance measures which were reported in $3 studies with a
similar population are reported in Table 2. No more than four
studies reported the same measure for any patient group, which
was insufficient for meta-analysis.
Studies which directly compared the performance of their
model to birth weight and/or gestational age (12 studies
[7,12,13,20,21,25–28,32,34,45]) showed that the multivariate
model performed better, with the exception of one study [25]
which restricted the prediction model to information routinely
available in a low-resource setting. Other prediction models
Figure 2. Classification of studies by the time at which a prediction can be made. Summary of prediction models by time of prediction. The
time of prediction is the point in time where a prediction can be made using the model. A model for antenatal prediction was reported in 5 studies,
for prediction at live birth in 17 studies, upon NICU admission in 8 studies, from the first day of life in 12 studies, and after the first day of life in 6
studies. Two studies do not specify when the data should be collected or when a prediction can be made. Studies marked with an asterisk met our
criteria for methodological quality.
doi:10.1371/journal.pone.0023441.g002
Prediction of Mortality in Very Premature Infants
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e23441developed in low-resource and mixed-resource settings do
outperform birth weight [27,32,34]. Of the 12 studies comparing
the model to birth weight and/or gestational age, the largest
differences reported were an AUC of 0.70 for birth weight
compared to an AUC of 0.89 for the multivariate model [20] and
an AUC of 0.78 for birth weight compared to an AUC of 0.90 for
the multivariate model (the CRIB-II score, p=0.03) [13].
However, since one was in an ELGA/BW population and the
other in a VLGA/BW population, it is not possible to say which
model would perform better in any one population.
The authors’ intended use of the prediction model was classified
as classification (5 studies), case-mix adjustment (15 studies),
Table 1. Summary of performance measures reported in the 41 development studies.
measure n studies lowest highest mean median
discrimination AUC 18/41 0.698 [32] 0.954 [21] 0.8583 0.87
calibration H-L p 19/41 ,0.01 [42] 0.99 [18] 0.5757 0.6255
accuracy % correct / accuracy 9/41 0.62 [43] 0.883 [14] 0.7857 0.79
PPV 14/41 0.44 [18] 0.84 [27] 0.703 0.75
NPV 15/41 0.522 [32] 0.94 [42] 0.7986 0.81
sensitivity 10/41 0.17 [25] 0.95 [7] 0.6474 0.72
specificity 13/41 0.32% [29] 1.00 [25] 0.7848 0.85
discrimination, calibration,
accuracy
R2 4/41 0.30 [17] 0.69 [41] 0.3588 0.39
range 15/41 27–52% [43] 1–98% [33] -- --
Overview of performance measures reported by $2 studies. At least one performance measure was required for inclusion; most studies reported more than one. A
summary of measures per study is given in Table S2, and the measures reported for each model are in Table S3. The heterogeneity of the studies precludes direct
comparison of model performance.
AUC = area under the curve; ideal =1.0 and chance =0.5.
R
2 = coefficient of determination; the proportion of variability that is accounted for by the model. ideal = 1.0.
H-L p = Hosmer-Lemeshow p value; any non-significant value indicates acceptable calibration.
% correct; ideal =1.0 and chance < %survival
2.
PPV = positive predictive value; ideal =1.0 and chance related to prevalence and cut-off.
NPV = negative predictive value; ideal =1.0 and chance related to prevalence and cut-off.
sensitivity; ideal =1.0 and chance related to prevalence.
specificity; ideal =1.0 and chance related to prevalence.
range = the range of probabilities generated by the model.
Note that performance measures of unvalidated models may be overestimated.
doi:10.1371/journal.pone.0023441.t001
Table 2. Comparison of predictive performance of models as reported in the development studies.
VLGA/BW, post-surfactant, developed countries, AUC
age/weight range mortality rate performance
Zernikow 1998 ,1500 g or ,32 w 8.3% AUC =0.954 (SD 0.015)
*
Parry 2003 ,=32 w 7.9% AUC =0.92 (SE 0.01)
Evans 2007 ,1500 g or ,32 w 6.8% AUC =0.83
ELGA/BW, post-surfactant, developed countries, AUC
Tyson 1996 501–800 g 33.5% AUC =0.76
Ambalavanan 2001 ,1000 g 34% AUC =0.87 (SE 0.03)
*
Ambalavanan 2005 401–1000 g 35% AUC =0.854 (SE 0.004)
*
Tyson 2008 401–1000 g and 22–25 w 42% AUC =0.753 (95% CI 0.737–0.769)
ELGA/BW, post-surfactant, developed countries, R
2
Ambalavanan 2001 ,1000 g 34% R
2 =0.36
Locatelli 2005 ,750 g and ,34 w 49.2% R
2 =0.69{
Gargus 2009 401–1000 g 34.4% R
2 =0.4175{
Studies which reported the same outcome measure were considered for comparison. Since the performance is only comparable in similar populations, the study
populations were compared on whether the population was VLGA/BW or ELGA/BW, from a developed or developing country, from the pre- or post- surfactant era, and
the reported mortality rate (an absolute difference of #10% was considered comparable). Only three categories contained more than two studies. All performance
measures for each prediction model are given in Table S3.
*multiple models, using best performance of those reported.
{performance assessed on development set, may be overestimated.
doi:10.1371/journal.pone.0023441.t002
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identifying predictive variables, 12 studies). Six suggested more
than one intended use (see Table S2).
Validation. Validation was performed for at least one
prediction model in 17/41 studies, most commonly split-sample
internal validation (14/17), with no validation in the original
publication but later published separately for an additional 2
studies. Only 7 studies developed models which were ever
validated in a later study, with 4 validated in more than one
additional study (NICHD [12], CRIB [13], SNAP-II and
SNAPPE-II [23], and CRIB-II [26]). Four of the development
studies compared their model to a previously published model,
thus providing validation of the other model: one comparing to the
NICHD model [27], three to CRIB [25,27] including the CRIB-II
study [26], and one to CRIB-II [32]. In all cases the new model
performed as well or better than its comparison, although in one
study this performance measure was taken on the development
sample [25], which will tend to overestimate performance. Four
additional studies included the CRIB [16,20,44] or SNAPPE-II
[31] score as an input variable.
Quality and quality assessment framework. A
framework was developed to assess the quality of the studies, in
terms of the quality of reporting and the quality of model
development. A summary of the framework is given in Figure 3,
the complete framework and the score of each study is given in the
supporting text S1. One study [24] could not be evaluated using
the framework, as it reported a score based on expert opinion
rather than statistical methods.
Reporting scores ranged from 11 to 38 from a possible 38 points
(median 28, interquartile range 24–33). One study scored 38/38
points on the reporting score [32]. In the other studies, common
areas for improvement included reporting of the percentages of
missing values and how they were handled, as only 17/40 studies
reported both. A measure of confidence for at least one main
performance measure was reported in 14/40 studies. Slightly more
(22/40) reported more than one performance measure for at least
one model, and 23/40 compared the performance of at least one
model to birth weight, gestational age, or a reference model.
Methodological scores ranged from 7 to 12 from a possible 12
points (median 10, IQR 9-12), with 12 meeting all of our
methodological criteria. The most common methodological
problem was lack of validation, with less than half (17/40 studies)
performing validation on a separate sample or using statistical
validation techniques such as bootstrapping. In 9 studies there was
some doubt about whether the population used to develop the
model was representative, and in 6 the number of patients was not
adequate to support the number of predicting variables.
The intended use of the model was classification in 2 studies
[10,13], case-mix adjustment in 7 [12,13,17,23,27,28,38], and
clinical decision-making in 5 [8,10,38,42,45]. The performance
measures reported were appropriate for classification and case-mix
adjustment, but only one of the five reported all performance
measures to assess the model for clinical decision making [10].
Discussion
Principal findings
This review identified 41 studies reporting on the development
of a prediction model of mortality in very premature infants.
There were 18 validation studies of existing prediction models and
no impact studies. Nearly all studies found that a multivariate
model predicted mortality better than birth weight or gestational
age alone. In addition to gestational age and birth weight, eight
variables frequently predicted survival: being of average size for
gestational age, female gender, non-white ethnicity, absence of
serious congenital malformations, use of antenatal steroids, higher
5-minute Apgar score, normal temperature on admission, and
clinical or laboratory measures indicating better respiratory status.
The included studies are heterogeneous in population and
mortality rate. Twelve studies met our minimum methodological
quality criteria, with eight for very premature infants and four for
extremely premature infants. Room for improvement was found in
the areas of reporting of model performance (reporting measures
which are comparable between studies and are consistent with the
stated objectives of the study), handling of missing values, and the
use of efficient internal validation methods.
Strengths and weaknesses
The primary strength of this study is in the systematic search
strategy and systematic assessment of the quality and content of
the included studies using a framework. There are of course
limitations to any search strategy and it is possible that relevant
articles may have been overlooked. Several choices have been
made in this work which result in trade-offs. Our inclusion criteria
intentionally excluded studies in a general NICU population, such
as the study on the original SNAP score [48]. While this excludes
some models with potential relevance, it ensures the relevance of
models for our population of interest. We chose to limit our list of
variables which were frequently found to be significant to those
which had been considered as input variables in ten or more
studies. The variables which we identified are thus more likely to
be important, but this excludes variables which have not yet been
extensively studied. We chose to limit our methodological score to
minimal criteria, which results in less stratification than in the
Figure 3. Summary of framework for assessing the quality of
studies reporting on the development of a new prediction
model. The quality framework consists of two parts, a methodological
score with minimal criteria and a reporting score. The complete
framework is available in the supporting text S1, along with an
assessment of each included study.
doi:10.1371/journal.pone.0023441.g003
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key question of whether the model was developed with sufficient
rigor to form the basis for further research.
Comparison to other studies
To our knowledge, this is the first systematic review of models
for the prediction of mortality in very premature infants. A review
was published in 2005 [3], summarizing 12 different scoring
systems for neonatal morbidity at all birth weights and gestational
ages. Six of those scoring systems, including CRIB, are also
included in this review. In the year 2000 a comparison was
published of the performance of 6 different scores, alone and in
combination with one another and with birth weight [49], on a
single VLBW population. The best model in that study was a
combination of birth weight, birth weight squared, SNAP at 24-h,
and Apgar ,7 at 5 min with an AUC of 0.930 and a Hosmer-
Lemeshow p value of 0.96, in contrast to birth weight alone which
had an AUC of 0.869 and a Hosmer-Lemeshow p value of 0.0005.
Implications
The primary audience of this systematic review are researchers
who wish to further the state of knowledge in this area by
developing, validating, or assessing the impact of prediction
models. Clinicians should be aware that multivariate models
including factors in addition to birth weight and gestational age
predict survival better than these two factors alone, although
generally only slightly better. The consistent survival advantage of
female infants and infants of non-white ethnicity are of particular
relevance to clinical decision-making.
Use of the prediction models. Prediction models have the
potential to assist clinical decision making, case-mix adjustment, or
classification. For clinical decision making, clinicians are often
uncertain about resuscitation and initiating mechanical ventilation
in infants at the edge of viability [50], where gestational age and
birth weight alone give an equivocal prognosis. The gestational
age and weight range of this group varies by year and by country,
but is currently around 23 to 27 weeks in the developed world.
Prediction models which are created with a smaller range of
gestational ages and birth weights are likely to be more useful for
clinical decisions in this group of infants, as the model will depend
less on weight and age. No study in this review explicitly stated
that the model was developed to assist with clinical decision
making in the group of infants where clinicians feel uncertain in
their clinical judgment, although the seven studies predicting
mortality in the youngest and smallest ELGA/BW infants
[36,38,39,41,44–46] may have been implicitly directed toward
this goal. Clinical predictions based on the appearance of the
infant at birth are often inaccurate [50,51], and it is known that
clinicians who over-predict death also tend to perform less
resuscitation and other therapies, leading to the potential for a
self-fulfilling prophecy [42]. The resuscitation policy and practices
at the hospitals where these models were developed likely affected
the outcome, and therefore possibly the prediction models.
Resuscitation policy was reported in only 10 studies (see Table
S3), although several others were multicenter studies which likely
varied in resuscitation policy, and several specifically mentioned
that resuscitation policy varied or was not known.
Of the aforementioned seven studies, two met our methodo-
logical quality criteria [38,45]. Both are by the same research
group and ‘‘take the perspective of a clinician deciding whether to
initiate mechanical ventilation.’’ Although the authors do not
report calibration or range in the more recent study, both models
are good candidates for further work in this area. A good approach
would be to determine which groups of infants pose a clinical
dilemma for the participating hospitals, by observing or asking
clinicians. Because preterm birth at very low gestational age is
rather rare, international collaboration may be required in order
to include sufficient numbers of infants to develop or validate a
model. If a prediction model is found to have good performance
on multiple measures, it can be externally validated and presented
in a form which is usable for clinicians (for example, a wall chart or
a computerized calculator, which can be very useful in counseling
parents), and assessed in an impact study.
Models which make predictions for a general VLGA/BW
population are most likely to be useful in classification, bench-
marking, or case-mix adjustment. Scores such as CRIB [13] and
SNAP-II [23] have been externally validated, but this review
found six additional studies meeting our methodological criteria
which predicted mortality for a general VLGA/BW population
[8,10,12,17,27,28]. These models could prove to be as good or
better than CRIB or SNAP. General prediction models may also
be recalibrated for a narrow range of maturity for clinical
prediction, but performance is likely to be poorer as maturity itself
is the largest predictor in most of these models. For the same
reason, any prediction model for a narrow gestational age or birth
weight range is likely to have poorer performance measures than a
general prediction model, but may still make significantly better
predictions than maturity or clinical intuition alone.
Variables. Users should be cautious when using prediction
models which include variables that can be affected by treatment
choices, and models which include subjective measures such as the
Apgar score. Fetuses or infants who appear subjectively unlikely to
survive may be treated differently than those who appear
healthier, leading to differences in mortality. Subjective
prognosis leading to different treatment decisions may explain
why seizures predicted poor outcome (3/6 studies) but not
intraventricular hemorrhage or periventricular leukomalacia (1/
12 studies).
Whether an input variable remains in the final model depends
on its ability to differentiate survivors from nonsurvivors, which
depends in part on the prevalence of the variable in the
population. For example, antenatal steroids are known to be
beneficial, but appear in the final model in only 11/20 studies. In
the other 9, antenatal steroids were either given routinely or rarely,
thus the population was homogeneous in that respect. This may
also explain why maturity was not significant in prediction models
restricted to 23–24 [46] and 25-week [44] infants, and 1000–
1500 g infants in a low-resource setting [16]. The importance of a
variable in the model is also strongly influenced by the other
variables which are included.
Study quality. This review identified three major areas for
improvement of study quality: handling of missing data, validation,
and reporting model performance. Simply omitting patients who
have missing data can bias the population, resulting in a
suboptimal model. Missing data can be handled by comparing
populations with and without missing data to check for bias,
imputing the missing values, or other appropriate techniques [2].
Most studies which performed an internal validation used a split
sample. Future research can be improved by using resampling or
bootstrapping techniques based on the whole study population, as
they provide good evidence of validity without reducing sample
size for model development [2]. Similarly, the most common
performance measure reported in these studies is the Hosmer-
Lemeshow p-value, a measure of calibration. This measure is
strongly affected by the choice of equal-sized groups (C) or equal-
interval groups (H), the choice of cut-points to create those groups,
and sample size, and cannot be used by itself to compare models
[52]. No one measure is ideal, and the best solution is to report two
Prediction of Mortality in Very Premature Infants
PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e23441or more measures appropriate for the intended purpose of the
model.
Future work
For clinical use, external validation of a prediction model and
impact studies are important indicators of its usefulness [53]. A
summary of the scope and quality of external validation could be
informative for future research. For clinicians and parents,
predicting severe morbidity in total and on subgroups of diseases
is equally important to decision-making. Although some models
incorporated both outcomes, models predicting severe morbidity
alone also warrant study. Meta-analyses focusing on specific
prediction variables, such as the gender of the child and ethnicity
of the child or mother, may help quantify the influence of those
variables and the physiologic and social mechanisms which
connect them to mortality.
Only four studies investigated the use of neural networks or
classification trees [21,29,40,42], three of which were by the same
research team. Further investigation of these alternatives to logistic
regression may be warranted [54]. Although some of the models
predict mortality for the youngest and smallest ELGA/BW infants,
no models were developed specifically for clinical prediction in
infants where gestational age and birth weight give an equivocal
prognosis. This may be due to the small number of infants who are
born at this early age, but international collaboration could yield
large enough data sets to develop and/or validate models for small
ranges of gestational age and birth weight within this population.
Models developed for the population at the tipping point of
survival, where clinical judgment is most difficult, have the most
potential to aid clinical decision making.
Conclusion
This systematic review provides an overview of existing research
in prediction of mortality in very preterm infants. Multivariate
models generally predict mortality better than birth weight or
gestational age alone. Eight common predictors were identified,
including a consistent survival advantage for female infants and
infants of non-white ethnicity. There are nine studies reporting
validated prediction models for classification or case-mix adjust-
ment which met our methodological criteria, though poor
reporting of model performance precludes comparison of the
predictive ability of these models. Future studies could be
improved by reporting measures which are comparable between
studies, reporting measures which are consistent with the stated
objectives of the study, and comparing performance to a reference
model. Better handling of missing data, better internal validation,
and additional external validation studies are also needed. Five
studies reported validated prediction models for clinical decision
making, two of which focus on the youngest and smallest of
premature infants. There are no studies of the impact of these
models on clinical decision making. Future prediction models
could focus on the narrow gestational age and weight ranges
where clinicians feel uncertain in delivering a prognosis. Such
models are most likely to help clinicians and parents in making the
difficult decisions common to the care of very preterm infants.
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